New Therapies Transforming Patient Care This Year
Key Approvals (FDA, March 2026) Industry Trends Takeaway: 2026 is shaping up as a landmark year for first-in-class therapies that […]
From Pilots to Platforms: How AI is Reshaping Pharma in 2026
AI is no longer experimental — in 2026, pharma companies are embedding AI into core infrastructure, spanning drug discovery, clinical